Cancer incidence and survival statistics for Northern Ireland 2012-2016

March 14, 2018, Queen's University Belfast

The Queen's University N. Ireland Cancer Registry (NICR) today released the number of new cancer cases diagnosed (incidence) in Northern Ireland in 2016. Legislation designating the Northern Ireland Cancer Registry (NICR) as an official producer of statistics came into place 1 April 2012. Website available at: .

The yearly average of incidence for patients diagnosed 2012-2016 is presented as a stable estimate of incidence in Northern Ireland (NI), and in various geographic groups. The release also updates cancer incidence trends and survival statistics 1993-2016.

Key facts and figures are presented below.

Cancer incidence 2012-2016

  • In the period 2012-2016 in addition to 3,718 per year of non-melanoma skin cancer (NMSC) there were 4,607 male and 4,632 female patients diagnosed with cancer each year during 2012-2016.
  • The most common cancers diagnosed among males between 2012 and 2016 were prostate (24% of all cancer in males), colorectal (14%) and lung (14%) while the most common cancers among women were breast (30% of all cancer in females), lung (13%) and colorectal (11%).
  • Cancer risk is strongly related to age with over 60% of cases occurring in people over the age of 65 and greatest for those aged 85-89 years.
  • Excluding NMSC the odds of developing a cancer by the age of 75 was 1 in 3.5 for men and 1 in 3.7 for women.

Cancer incidence trends

  • Over the last ten years the number of cancer cases (excluding NMSC) has increased from 4,044 among men and 3,885 among women in 2007 to 4,629 among men and 4,817 among women in 2016. These increases are largely due to our ageing population.
  • After adjusting for age, following a steady increase in cancer incidence rates in males since 1999, rates decreased during 2011 to 2016 by an average of 1.5% per year. In contrast, since 2001 female incidence rates have shown a continuous increase by an average of 1.0% per year. These changes reflect increasing rates of lung cancer linked to historic smoking trends among women and increasing breast cancer incidence.
  • In 2016, for the first time, there were more cases of lung cancer diagnosed in women than men with 698 cases compared to 653, respectively. Lung rates (adjusted for age) are declining in men however continue to significantly increase in women at almost 6% per year since 2010.
  • Incidence rates of colorectal cancer have been decreasing in both men and since 2012 and 2013, respectively, by 5% per year.
  • The number of in situ-cervix cases and age-adjusted incidence rates are markedly lower in 2016 compared to the previous 10 years. There were 920 cases diagnosed in 2016 compared to 1,162 cases in 2015.

Incidence rates by socio-economic deprivation

  • Cancer incidence is 10% higher in the most deprived areas compared to the Northern Ireland average and 4% lower in the least deprived areas. This varies significantly by cancer site with incidence of lung, head & neck, oesophagus, stomach, male-colorectal and cervix higher in the most deprived areas and incidence of melanoma and breast cancer higher in the least deprived areas.

Survival statistics updated

  • Over 55% of all cancer patients survived five years after diagnosis, 20% of patients died within 6 month of diagnosis, while over 70% of patients were alive one year after diagnosis.
  • Five-year net survival rates, which take account of background mortality, for patients diagnosed between 2006 to 2010 were as follows: female breast (81.7%), colorectal (57.6%), prostate (88.7%), lung (10.4%). These survival rates have all shown improvement compared to patients diagnosed in the period 1993 to 1999, although gains in cancer survival were slight.
  • Comparisons of five-year survival for diagnosed 2006-2010 to those diagnosed 1993-2000 show survival improvements for all cancers except bladder cancer which has decreased in both females and males. This is likely linked with coding changes so not comparing the same types of bladder cancer over time. Comparing these two time periods, significant improvements in leukaemia and oesophageal cancer five-year survival have been observed, likely a reflection of improvements in treatments.
  • With regard to cancer prevalence, at the end of 2016 there were 61,038 people living in NI who had been diagnosed with since 1993. Of these, 43.7% were male, 47.4% were aged 70 and over and 10.9% had been diagnosed in the previous year.

Explore further: Cancer mortality in the US continues decades-long drop

Related Stories

Cancer mortality in the US continues decades-long drop

January 4, 2018
The cancer death rate dropped 1.7% from 2014 to 2015, continuing a drop that began in 1991 and has reached 26%, resulting in nearly 2.4 million fewer cancer deaths during that time.

Differences in cancer survival by type of insurance

December 4, 2017
(HealthDay)—From 1997 to 2014, improvements in cancer survival were mainly limited to patients with private or Medicare insurance, according to a study published online Nov. 30 in JAMA Oncology.

Incidence of early-stage breast CA, CRC up with ACA adoption

November 6, 2017
(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2 in JAMA Oncology.

Breast cancer statistics, 2017: Gap in death rates between whites, blacks closing in several states

October 3, 2017
Overall breast cancer death rates dropped 39 percent between 1989 and 2015, averting 322,600 breast cancer deaths during those 26 years. And while black women continue to have higher breast cancer death rates than whites ...

New Zealand's colorectal cancer rates are on the rise in young adults

April 5, 2017
A recent analysis found a decrease in the overall incidence of colorectal cancer in New Zealand, but an increased incidence of rectal cancer in those under 50 years of age.

Recommended for you

Ovarian cancer cells switched off by 'unusual' mechanism

June 19, 2018
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells.

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

Researchers create novel combination as potential therapy for high-risk neuroblastoma

June 18, 2018
Researchers at VCU Massey Cancer Center in Richmond, Virginia, have identified a promising target to reverse the development of high-risk neuroblastoma and potentially inform the creation of novel combination therapies for ...

Standard myelofibrosis drug can awaken 'dormant' lymphoma

June 18, 2018
Most patients with myelofibrosis, a rare chronic disorder of the haematopoietic cells of the bone marrow, benefit from drugs from the JAK2 inhibitor class: symptoms are relieved, survival extended and general quality-of-life ...

Genomics offers new treatment options for infants with range of soft tissue tumors

June 18, 2018
The genetic causes of a group of related infant cancers have been discovered by scientists at the Wellcome Sanger Institute, the University of Wuerzburg and their collaborators. Whole genome sequencing of tumours revealed ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.